The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia
Abstract
Fibromyalgia is a prevalent and burdensome disorder characterized by chronic widespread pain and complex comorbid symptoms. To develop better treatments for pain-centered fibromyalgia symptoms, there is still a need for animal models which mimic the features of fibromyalgia patients. In the present study, we have established a fibromyalgia animal model by utilizing a never-before-published pharmacological effect of reserpine. Repeated administration of reserpine (1mg/kg s.c., once daily, for three consecutive days) causes a significant decrease in the muscle pressure threshold and tactile allodynia, which are sustained for 1week or more in both male and female rats. This treatment regimen decreases the amount of biogenic amines (dopamine, norepinephrine, and 5-hydroxytryptamine) in the spinal cord, thalamus, and prefrontal cortex, which are deeply involved in pain signal processing. It also significantly increases immobility time in the forced swim test, which is indicative of depression, a common comorbid symptom of fibromyalgia. Pregabalin, duloxetine, and pramipexole significantly attenuated the reserpine-induced decrease in muscle pressure threshold, but diclofenac did not. The validity of the use of this reserpinized animal as a fibromyalgia model is demonstrated from three different aspects, i.e., face validity (manifestation of chronic pain and comorbid symptoms), construct validity (dysfunction of biogenic amine-mediated central nervous system pain control is involved), and predictive validity (similar responses to treatments used in fibromyalgia patients). This animal model is expected to contribute to the better understanding of fibromyalgia pathophysiology and the evaluation of drugs, especially those which would activate biogenic amine system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Ethical guidelines for investigations of experimental pain in conscious animals.
Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762 · cited 1×
“Experiments were conducted in accordance with the guidelines of the Committee for Research and Ethical Issues of IASP on using laboratory animals [63].”
MethodQuantitative assessment of tactile allodynia in the rat paw
Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M., & Yaksh, T. L. (1994) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)90144-9 · Cited by 7,697
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry
Basbaum, A. I., & Fields, H. L. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001521 · Cited by 2,687
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126 · cited 1×
“Pregabalin has been used in the treatment of patients with neuropathic pain [15].”
BackgroundFunctional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia
Gracely, R. H., Petzke, F., Wolf, J. M., & Clauw, D. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10225 · Cited by 1,263
Neuroanatomy of the pain system and of the pathways that modulate pain
Willis, W. D., & Westlund, K. N. (1997) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199701000-00002 · Cited by 924
Fibromyalgia and overlapping disorders: The unifying concept of central sensitivity syndromes
Yunus, M. B. (2007) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.12.009 · Cited by 780
Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L. K., Martin, S. A., Sharma, U., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20983 · Cited by 654
Russell, I. J., Vaeroy, H., Javors, M., & Nyberg, F. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350509 · Cited by 547
Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia
Sluka, K. A., Kalra, A., & Moore, S. A. (2001) · Muscle & Nerve · doi:10.1002/1097-4598(200101)24:1<37::aid-mus4>3.0.co;2-8 · Cited by 503
Functional imaging of pain in patients with primary fibromyalgia.
Cook, D. B., Lange, G., Ciccone, D. S., Liu, W., Steffener, J., & Natelson, B. H. (2004) · PubMed · Cited by 453
Goldenberg, D. L., Felson, D. T., & Dinerman, H. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780291110 · Cited by 439
Descending modulation in persistent pain: an update
Ren, K., & Dubner, R. (2002) · Pain · doi:10.1016/s0304-3959(02)00368-8 · Cited by 428
Chronic widespread pain and fibromyalgia: what we know, and what we need to know
Clauw, D. J., & Crofford, L. J. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00035-4 · Cited by 381
Enhanced temporal summation of second pain and its central modulation in fibromyalgia patients
Price, D. D., Staud, R., Robinson, M. E., Mauderli, A. P., Cannon, R., & Vierck, C. J. (2002) · Pain · doi:10.1016/s0304-3959(02)00053-2 · Cited by 374
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 370
Russell, J. I., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D. J., Chappell, A. S., & Arnold, L. M. (2008) · Pain · doi:10.1016/j.pain.2008.02.024 · Cited by 367
Vesicular neurotransmitter transporters: from bacteria to humans.
Schuldiner, S., Shirvan, A., & Linial, M. (1995) · Physiological Reviews · doi:10.1152/physrev.1995.75.2.369 · Cited by 326
Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y., & Simmons, R. M. A. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070656 · Cited by 291
Holman, A. J., & Myers, R. R. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21191 · Cited by 289
Mease, P. J., Russell, I. J., Arnold, L. M., Florian, H., Young, J. P., Martin, S. A., & Sharma, U. (2008) · PubMed · Cited by 288
Bennett, R. M. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.4.385 · Cited by 255
MEASE, P. J., CLAUW, D. J., GENDREAU, R. M., RAO, S. G., KRANZLER, J., CHEN, W., & PALMER, R. H. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080734 · Cited by 248
Dooley, D. J., Donovan, C. M., & Pugsley, T. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39009-3 · Cited by 217
Field, M. J., Bramwell, S., Hughes, J., & Singh, L. (1999) · Pain · doi:10.1016/s0304-3959(99)00111-6 · Cited by 213
Mechanisms of Disease: pain in fibromyalgia syndrome
Staud, R., & Rodriguez, M. E. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0091 · Cited by 211
Efficacy of Tramadol in Treatment of Pain in Fibromyalgia
Russell, J. I., Kamin, M., Bennett, R. M., Schnitzer, T. J., Green, J. A., & Katz, W. A. (2000) · JCR: Journal of Clinical Rheumatology · doi:10.1097/00124743-200010000-00004 · Cited by 197
Evidence of involvement of central neural mechanisms in generating fibromyalgia pain
Staud, R. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0038-5 · Cited by 183
Pathogenesis of fibromyalgia – A review
Ablin, J. N., Neumann, L., & Buskila, D. (2008) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.09.010 · Cited by 180
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat
COLPAERT, F. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90110-9 · Cited by 169
Altered brain activity during pain processing in fibromyalgia
BURGMER, M., POGATZKIZAHN, E., GAUBITZ, M., WESSOLECK, E., HEUFT, G., & PFLEIDERER, B. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.09.008 · Cited by 165
Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats☆
Schäfers, M., Sorkin, L. S., & Sommer, C. (2003) · Pain · doi:10.1016/s0304-3959(03)00115-5 · Cited by 165
Stress and dopamine: implications for the pathophysiology of chronic widespread pain
Wood, P. B. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2003.10.013 · Cited by 163
A new animal model for assessing mechanisms and management of muscle hyperalgesia
Kehl, L. J., Trempe, T. M., & Hargreaves, K. (2000) · Pain · doi:10.1016/s0304-3959(99)00282-1 · Cited by 150
Biology and therapy of fibromyalgia. New therapies in fibromyalgia.
Arnold (2006) · Arthritis Research & Therapy · doi:10.1186/ar1971 · Cited by 145
Mierau, J., & Schingnitz, G. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90024-x · Cited by 139
Legangneux, E., Mora, J. J., Spreux‐Varoquaux, O., Thorin, I., Herrou, M., Alvado, G., & Gomeni, C. (2001) · Rheumatology · doi:10.1093/rheumatology/40.3.290 · Cited by 123
Yunus, M. B., Masi, A. T., & Aldag, J. C. (1989) · PubMed · Cited by 119
Tamae, A., Nakatsuka, T., Koga, K., Kato, G., Furue, H., Katafuchi, T., & Yoshimura, M. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.091843 · Cited by 117
Leith, N. J., & Barrett, R. J. (1980) · Psychopharmacology · doi:10.1007/bf00433801 · Cited by 104
Purine nucleoside ? mediated immobility in mice: Reversal by antidepressants
Kulkarni, S. K., & Mehta, A. K. (1985) · Psychopharmacology · doi:10.1007/bf00429665 · Cited by 103
Rooks, D. (2007) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328040bffa · Cited by 101
Neurobiological concepts of fibromyalgia - the possible role of descending spinal tracts
Mense, S. (2000) · Scandinavian Journal of Rheumatology · doi:10.1080/030097400446599 · Cited by 98
Pathophysiologic mechanisms of fibromyalgia and its related disorders.
Bradley, L. A. (2008) · PubMed · Cited by 97
Heymann, R. E., Helfenstein, M., & Feldman, D. P. (2001) · PubMed · Cited by 95
The behavioural effects of pramipexole, a novel dopamine receptor agonist
Maj, J., Rogóż, Z., Skuza, G., et al. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00066-6 · Cited by 87
The effect of local and systemic application of dopaminergic agents on tail flick latency in the rat
Barasi, S., & Duggal, K. N. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90001-9 · Cited by 81
Malt, E. A., Ólafsson, S., Aakvaag, A., Lund, A., & Ursin, H. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00025-3 · Cited by 71
Pharmacological therapies in fibromyalgia
Rao, S. G., & Bennett, R. M. (2003) · Best Practice & Research Clinical Rheumatology · doi:10.1016/s1521-6942(03)00030-5 · Cited by 68
Stress-induced muscle and cutaneous hyperalgesia: Differential effect of milnacipran
Suárez-Roca, H., Quintero, L., Arcaya, J. L., Maixner, W. D., & Rao, S. G. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.03.010 · Cited by 63
Finch, L., & Leach, G. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb12895.x · Cited by 59
Brain IL-1 beta was involved in reserpine-induced behavioral depression in rats.
Huang, Q., Jiang, H., Hao, X.-L., & Minor, T. R. (2004) · PubMed · Cited by 34
Novel pharmacotherapy for fibromyalgia
Wood, P. B., Holman, A. J., & Jones, K. D. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.829 · Cited by 30
Antibody panels in idiopathic polyneuropathy and motor neuron disease
Wolfe, G. I., El-Feky, W. H., Katz, J., Bryan, W. W., Wians, F. H., & Barohn, R. J. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199710)20:10<1311::aid-mus15>3.0.co;2-5 · Cited by 24
Cytokine-purine interactions in behavioral depression in rats
Minor, T. R., Huang, Q., & Foley, E. A. (2003) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02688853 · Cited by 19
Depletion and repletion of cortical tissue and dialysate 5-HT after reserpine
Heslop, K. E., & Curzon, G. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90088-4 · Cited by 16
Current trends in fibromyalgia research
Marcus, D. A. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1687 · Cited by 4
Cited by
Neurobiology of fibromyalgia and chronic widespread pain
Sluka, K. A., & Clauw, D. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.006 · Cited by 671
“There is also an increase in immobility time in the forced swim test, a test for depression which a common comorbid symptom of fibromyalgia (Nagakura et al., 2009).”
BackgroundPassive transfer of fibromyalgia symptoms from patients to mice
Goebel, A., Krock, E., Gentry, C., Israel, M. R., Jurczak, A., Urbina, C. M., Sandor, K., Vastani, N., Maurer, M., Cuhadar, U., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144201 · Cited by 278
Chiappini, S., & Schifano, F. (2016) · CNS Drugs · doi:10.1007/s40263-016-0359-y · Cited by 189
Animal models of fibromyalgia: What is the best choice?
Brum, E. S., Becker, G., Fialho, M. F. P., & Oliveira, S. M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107959 · Cited by 71
El-Marasy, S. A., El Awdan, S. A., Hassan, A., Ahmed-Farid, O. A., & Ogaly, H. A. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109329 · Cited by 50
Metadata
- Authors
- Nagakura, Y., Oe, T., Aoki, T., & Matsuoka, N.
- Venue
- Pain
- Published
- 2009-11
- Volume
- 146
- Issue
- 1
- Pages
- 26-33
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W1978053355
- Cited by
- 256
- References
- 61
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.